This is a prospective, open lable studies conducted in 115 hospital to compare between thromboectomy and Recombinant Tisue Plasminogen Activator only to evaluate the eficacy and safety of endovascular treatment in basilar artery occlusion stroke patients
Acute basilar artery thrombosis is associated with a poor prognosis. Prevalence of basilar artery occlusion are not known. Although basilar artery occlusion has been reported in 2 per 1000 autopsy cases, basilar artery thrombosis may, in stroke registries, explain as many as 27% of ischemic strokes occurring in the posterior circulation.Various treatments were tried in groups of patients with vertebrobasilar territory infarction but evidence based was not cleared previous studies. Therefore, we conduct this study to evaluate the eficacy and safety of endovascular treatment in basilar artery occlusion stroke patients
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
109
Thromboectomy in Basilar Artery Occlusion patients
NIHSS in patients wtih Basilar Artery Occlusion Stroke after 24hour admission
NIHSS in patients wtih Basilar Artery Occlusion Stroke after 24hour admission
Time frame: 24 hours from admission
Survival rate in patients with Basilar Artery Occlusion Stroke
Survival rate in patients with Basilar Artery Occlusion Stroke
Time frame: 3 months from admission
mRS in patients with Basilar Artery Occlusion Stroke
mRS in patients with Basilar Artery Occlusion Stroke
Time frame: 3 months from admission
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.